Literature DB >> 25156069

Clearing the way for tau immunotherapy in Alzheimer's disease.

Abigail Herrmann1, Tara Spires-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25156069     DOI： 10.1111/jnc.12845

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  9 in total

1.  Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies.

Authors:  Jun Zhao; Ruth Nussinov; Buyong Ma
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

Review 2.  Immunotherapy Applied to Neuropsychiatric Disorders: a New Perspective of Treatment.

Authors:  Pedro Luis Prior
Journal:  J Mol Neurosci       Date:  2015-05-31       Impact factor: 3.444

Review 3.  Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.

Authors:  Bianca Gonzalez; Edsel M Abud; Abigail M Abud; Wayne W Poon; Karen H Gylys
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 4.  Anti-dementia medications: current prescriptions in clinical practice and new agents in progress.

Authors:  Florindo Stella; Márcia Radanovic; Paulo Renato Canineu; Vanessa J R de Paula; Orestes V Forlenza
Journal:  Ther Adv Drug Saf       Date:  2015-08

5.  Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies.

Authors:  Gabriela A N Crespi; Stefan J Hermans; Michael W Parker; Luke A Miles
Journal:  Sci Rep       Date:  2015-04-16       Impact factor: 4.379

Review 6.  Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.

Authors:  Alice Bittar; Urmi Sengupta; Rakez Kayed
Journal:  NPJ Vaccines       Date:  2018-02-27       Impact factor: 7.344

7.  Early diagnosis and treatment of Alzheimer's disease: new definitions and challenges.

Authors:  Marcos Pais; Luana Martinez; Octávio Ribeiro; Júlia Loureiro; Romel Fernandez; Leandro Valiengo; Paulo Canineu; Florindo Stella; Leda Talib; Marcia Radanovic; Orestes V Forlenza
Journal:  Braz J Psychiatry       Date:  2020-01-24       Impact factor: 2.697

8.  Persistent repression of tau in the brain using engineered zinc finger protein transcription factors.

Authors:  Susanne Wegmann; Sarah L DeVos; Bryan Zeitler; Kimberly Marlen; Rachel E Bennett; Marta Perez-Rando; Danny MacKenzie; Qi Yu; Caitlin Commins; Riley N Bannon; Bianca T Corjuc; Alison Chase; Lisa Diez; Hoang-Oanh B Nguyen; Sarah Hinkley; Lei Zhang; Alicia Goodwin; Annemarie Ledeboer; Stephen Lam; Irina Ankoudinova; Hung Tran; Nicholas Scarlott; Rainier Amora; Richard Surosky; Jeffrey C Miller; Ashley B Robbins; Edward J Rebar; Fyodor D Urnov; Michael C Holmes; Amy M Pooler; Brigit Riley; H Steve Zhang; Bradley T Hyman
Journal:  Sci Adv       Date:  2021-03-19       Impact factor: 14.136

9.  Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta.

Authors:  Emily Miyoshi; Tina Bilousova; Mikhail Melnik; Danyl Fakhrutdinov; Wayne W Poon; Harry V Vinters; Carol A Miller; Maria Corrada; Claudia Kawas; Ryan Bohannan; Chad Caraway; Chris Elias; Katherine N Maina; Jesus J Campagna; Varghese John; Karen Hoppens Gylys
Journal:  Lab Invest       Date:  2021-08-30       Impact factor: 5.662
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.